A sensitive chemiluminescent immunoassay for point-of-care testing of repaglinide in natural dietary supplements and serum

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 7, 2015, Pages 1973-1980

  Zheng, Lei ^a   Wang, Jing ^a   Wang, Yufen ^a   Song, Zhaorui ^a   Dong, Yaqing ^a   Yin, Yongmei ^a   Eremin, Sergei A ^b   Meng, Meng ^a   Xi, Rimo ^a  

^a NANKAI UNIVERSITY   (China)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Antibody; Chemiluminescent immunoassay; Natural dietary ingredients; Repaglinide

Indexed keywords

ANTIBODIES; ANTIGENS; BODY FLUIDS; CHEMICAL DETECTION; CHEMILUMINESCENCE; FOOD ADDITIVES; IMMUNOLOGY; NUTRITION; VITAMINS;

CHEMILUMINESCENT IMMUNOASSAYS; HORSERADISH PEROXIDASE; LIMIT OF QUANTIFICATIONS; NATURAL DIETARY INGREDIENTS; POINT-OF-CARE TESTING; POLYCLONAL ANTIBODY; REPAGLINIDE; SIGNAL AMPLIFICATIONS;

DIETARY SUPPLEMENTS;

ARMORACIA RUSTICANA;

CARBAMIC ACID DERIVATIVE; PIPERIDINE DERIVATIVE; REPAGLINIDE;

ANALYSIS; BLOOD; DIET SUPPLEMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL INFORMATION SYSTEM; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; LUMINESCENCE;

CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIETARY SUPPLEMENTS; HUMANS; IMMUNOASSAY; LIMIT OF DETECTION; LUMINESCENCE; PIPERIDINES; POINT-OF-CARE SYSTEMS;

EID: 84928640617     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8462-3     Document Type: Article

References (17)

1. Owens DR (1998) Repaglinide-prandial glucose regulator: a new class of oral antidiabetic drugs. Diabet Med 15:S28-S36. doi: 10.1002/(SICI)1096-9136(1998120)
2. Bech P, Moses R, Gomis R (2003) The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naive type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 12:413-425. doi: 10.1023/A:1023495106160
3. Hasslacher C (2003) Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function. Diabetes Care 26:886-891. doi: 10.2337/diacare.26.3.886
4. Hatorp V, Huang WC, Strange P (1999) Pharmacokinetic profiles of repaglinide in elderly subjects with type 2 diabetes. J Clin Endocrinol Metab 84:1475-1478. doi: 10.1210/jc.84.4.1475
5. Gumieniczek A, Berecka A, Hopkala H (2005) Quantitative analysis of repaglinide in tablets by reversed-phase thin-layer chromatography with densitometric UV detection. J Planar Chromatogr Mod TLC 18:155-159. doi: 10.1556/JPC.18.2005.2.12
6. Gandhimathi M, Ravi TK, Renu SK (2003) Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection. Anal Sci 19:1675-1677. doi: 10.2116/analsci.19.1675
7. Soni LK, Narsinghani T, Jain M (2012) Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage form. J Liq Chromatogr Relat Technol 35:385-392. doi: 10.1080/10826076.2011.601492
8. Ho EN, Yiu KC, Wan TS, Stewart BD, Watkins KL (2004) Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry. J Chromatogr B 811:65-73. doi: 10.1016/j.jchromb.2004.03.070
9. Zhang J, Gao F, Guan X, Sun YT, Gu JK, Fawcett JP (2011) Determination of repaglinide in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Acta Pharm Sin B 1:40-45. doi: 10.1016/j.apsb.2011.04.004
10. Jiladia MA, Pandya SS (2009) Estimation of repaglinide in bulk and tablet dosage forms by HPTLC method. Int J Pharm Pharm Sci 1(Supp 1):141-144
11. De Boever J, Kohen F, Usanachitt C, Vandekerckhove D, Leyseele D, Vandewalle L (1986) Direct chemiluminescence immunoassay for estradiol in serum. Clin Chem 32:1895-1900
12. Dodeigne C, Thunus L, Lejeune R (2000) Chemiluminescence as diagnostic tool. A review. Talanta 51:415-439. doi: 10.1016/S0039-9140(99)00294-5
13. Maters AW, Wright CV, Lee MT, Schwichtenberg G, Detrick B (2012) Detection of type-specific antibodies to HSV-1 and HSV-2: comparative analysis of a chemiluminescence immunoassay with a conventional ELISA. Diagn Microbiol Infect Dis 73:273-274. doi: 10.1016/j.diagmicrobio.2012.03.023
14. Zhang Y, Lu S, Liu W, Zhao C, Xi R (2007) Preparation of anti-tetracycline antibodies and development of an indirect heterologous competitive enzyme-linked immunosorbent assay to detect residues of tetracycline in milk. J Agric Food Chem 55:211-218. doi: 10.1021/jf062627s
15. Hermanson GT (2013) Vaccines and immunogen conjugates. Bioconjugate techniques, 3rd edn, vol 19. Pierce Biotechnology/Thermo Fisher Scientific, Rockford, pp 839-865. doi: 10.1016/B978-0-12-382239-0.00019-4
16. Xin TB, Chen H, Lin Z, Liang SX, Lin JM (2010) A secondary antibody format chemiluminescence immunoassay for the determination of estradiol in human serum. Talanta 82:1472-1477. doi: 10.1016/j.talanta.2010.07.023
17. Qin QP, Peltola O, Pettersson K (2003) Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin. Clin Chem 49:1105-1113. doi: 10.1373/49.7.1105